Zogenix (ZGNX) Tops Q3 EPS by 7c, Maintains Guidance

Zogenix (NASDAQ: ZGNX) reported Q3 EPS of ($0.09), $0.07 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $8.3 million.

2014 Financial Guidance

The Company reiterates its 2014 financial guidance with the following update:

Expecting combined research and development and selling, general and administrative expenses of $25 million to $27 million for the fourth quarter, resulting in 2014 spending at the low end of the full-year range previously provided.

For earnings history and earnings-related data on Zogenix (ZGNX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery